ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

ANANDREET SEKHON MD

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,532Medicare Part D Prescriptions Filled, Including Refills

Rank: 283 out of 2888

$3,092 Total Retail Price of All Prescriptions

Rank: 2885 out of 2888

201 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 201 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

1% of this provider’s 12,292 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$0 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

67 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
ASPIRIN EC 594 533 1 238
OYSTER SHELL CALCIUM W-VIT D 487 431 10 2 244
LEVOTHYROXINE SODIUM 412 379 3 1
DOK 379 363 10 4 285
MULTIVITAMINS 356 332 10 5 260
LORATADINE 282 255 6 317
ENALAPRIL MALEATE 280 256 7 49
LISINOPRIL 280 274 7 3
AMLODIPINE BESYLATE 276 265 9 5
GABAPENTIN 269 246 10 13
ALENDRONATE SODIUM 260 248 11 23
SIMVASTATIN 252 226 12 2
OMEPRAZOLE 252 233 12 7
PANTOPRAZOLE SODIUM 242 229 14 33
LOVASTATIN 236 201 15 41
MAPAP 236 214 15 311
METOPROLOL SUCCINATE 213 201 17 11
TRAZODONE HCL 206 190 18 43
NAMENDA 204 204 19 34
HYDROCHLOROTHIAZIDE 201 166 20 15
METFORMIN HCL 200 174 21 8
METOPROLOL TARTRATE 186 156 22 10
SERTRALINE HCL 176 176 23 27
DONEPEZIL HCL 151 151 24 26
FUROSEMIDE 145 126 25 6
PLAVIX 143 126 26 40
LOSARTAN POTASSIUM 135 132 27 18
CARVEDILOL 131 120 28 21
CLOPIDOGREL 130 114 29 30
SENNA 125 113 30 312
HYDROCODONE-ACETAMINOPHEN 122 122 S3 31 4
FERROUS SULFATE 119 119 32 397
POLYETHYLENE GLYCOL 3350 118 106 33 93
VITAMIN B-12 116 116 34 432
WARFARIN SODIUM 113 113 35 22
REFRESH CELLUVISC 112 109 10 36 443
DIABETIC TUSSIN EX 110 100 10 37 476
QUETIAPINE FUMARATE 109 109 38 66
TAMSULOSIN HCL 99 99 39 29
METAMUCIL 98 90 10 40 365
LANTUS 91 58 41 45
SINGULAIR 87 87 42 85
KLOR-CON M20 85 85 43 90
ESCITALOPRAM OXALATE 83 83 44 62
MYTAB GAS 72 63 10 45 516
VITAMIN A & D 70 68 10 46 403
ASPIRIN 69 56 47 341
TRAMADOL HCL 67 67 48 16
MUSCLE RUB 65 63 10 49 535
GEMFIBROZIL 65 65 49 98
CILOSTAZOL 64 51 51 165
SEROQUEL 63 63 52 143
SURE COMFORT ALCOHOL 62 45 53 544
ZINC OXIDE 60 60 10 54 553
EXELON 57 57 55 106
MULTILEX-T-M WITH MINERALS 56 56 10 56 418
DETROL LA 55 55 57 192
LANTUS SOLOSTAR 54 54 58 92
CYMBALTA 52 28 59 44
DOC-Q-LACE 52 50 59 448
OCUVITE 52 52 10 59 586
IBUPROFEN 51 33 62 87
GLIPIZIDE 51 38 62 50
LEVETIRACETAM 51 40 62 103
LACTULOSE 50 50 65 111
FELODIPINE ER 50 37 65 175
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.